Esp Culture System II - Myco Susceptibility Testing

FDA 510(k) K972772 · Trek Diagnostic Systems, Inc.

Substantially Equivalent

510(k) numberK972772

Submission

Device name
Esp Culture System II - Myco Susceptibility Testing
Applicant
Trek Diagnostic Systems, Inc.
Westlake, OH, US
Received
July 24, 1997
Decision date
July 13, 1999
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
MJA – Susceptibility Test Powders, Antimycobacterial
Device class
Class II (moderate risk)
Regulation
21 CFR 866.1640
Specialty
Microbiology

Other 510(k)s with product code MJA

510(k)DeviceApplicantDecision
K052323Versatrek Myco Pza KitMJA · Traditional Trek Diagnostic Systems, Inc.01/19/2006SE
K021582Bactec Mgit 960 Pza KitMJA · Traditional Becton, Dickinson & CO07/13/2002SE
K014123Bactec Mgit 960 Sire KitsMJA · Traditional Becton, Dickinson & CO04/19/2002SE
K003062Bactec Mgit 960 Sir KitsMJA · Traditional Bd Becton Dickinson Vacutainer Systems Preanalytic06/06/2001SE

More from Bd Becton Dickinson Vacutainer Systems Preanalytic

510(k)DeviceDecision
K133038Sensititre Yeastone Susceptibility PlatesNGZ · Traditional 01/31/2014SE
K112276VizionJWY · Traditional 11/16/2011SE
K111615Sensititre 18-24 HR Susceptibility PlatesJWY · Traditional 11/08/2011SE
K110583Sensititre OptireadLRG · Traditional 09/22/2011SE
K103532Autoreader 2LRG · Traditional 08/26/2011SE
K111429Sensititre (R) HP Mic Susceptibility Plate with Cefaroline (0.004-8UG/ML) and the…JWY · Traditional 08/18/2011SE
K103456The Sensititre AimLIE · Traditional 06/22/2011SE
K110331Sensititre Aim (TM)LIE · Traditional 04/27/2011SE
K093741Sensitive Haemophilus Influenzae, Streptococcus Pneumonia, (HP) Mic Susceptibility PlatesJWY · Traditional 02/25/2010SE
K093865Sensititre 18-24HR Susceptibility PlatesJWY · Traditional 02/17/2010SE

Questions and answers

When was Esp Culture System II - Myco Susceptibility Testing cleared by the FDA?

Esp Culture System II - Myco Susceptibility Testing (K972772) received a 510(k) decision of Substantially Equivalent on July 13, 1999, 719 days after the submission was received.

What is the product code of K972772?

The FDA product code is MJA – Susceptibility Test Powders, Antimycobacterial, a Class II (moderate risk) device regulated under 21 CFR 866.1640.